Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Clin Oncol (R Coll Radiol) ; 35(12): 801-810, 2023 12.
Article in English | MEDLINE | ID: mdl-37777357

ABSTRACT

AIMS: Despite the breast being a mobile organ, there is currently no standard suitable immobilisation device to optimise radiotherapy for women with larger breasts treated after a wide local excision. The SuPPORT 4 All (S4A) bra was co-designed with patients and radiotherapy professionals. The purpose of this study was to test the feasibility of using the S4A bra in the existing breast cancer radiotherapy pathway. MATERIALS AND METHODS: A randomised feasibility trial was conducted in a single institution; the primary feasibility endpoint was the recruitment of 50 participants. Efficacy endpoints were also tested, including assessment of skin reactions, dose to organs at risk and patient comfort. Fifty women were randomised to receive either standard radiotherapy with no immobilisation (control) or radiotherapy with the S4A bra (intervention). A separate planning study was undertaken on the cases randomised to receive the S4A bra. Participants in the intervention arm (S4A bra) underwent two planning computed tomography scans, one with the bra on and one without the bra; allowing direct comparison of organs at risk data for S4A bra versus no bra. RESULTS: All women who started radiotherapy wearing the S4A bra completed treatment with the bra; patient comfort did not change across the 3 weeks of treatment. Positional accuracy using the bra was comparable with existing published accuracy for methods without immobilisation. The mean ipsilateral lung doses showed some improvement when positioning with the S4A bra was compared with the no bra set-up (3.72 Gy versus 4.85 Gy for right-sided cases, 3.23 Gy versus 3.62 Gy for left-sided cases). CONCLUSIONS: The S4A bra is feasible to use in the radiotherapy pathway with good patient adherence. The S4A bra has potential to reduce dose to organs at risk (specifically ipsilateral lung dose) while maintaining good breast tissue coverage, and improved patient dignity, warranting further investigation on a larger scale.


Subject(s)
Breast Neoplasms , Breast , Humans , Female , Radiotherapy Dosage , Feasibility Studies , Radiotherapy Planning, Computer-Assisted/methods , Lung , Breast Neoplasms/radiotherapy
2.
Clin Oncol (R Coll Radiol) ; 30(9): 548-555, 2018 09.
Article in English | MEDLINE | ID: mdl-29934104

ABSTRACT

AIMS: To analyse outcomes in metastatic castrate-resistant prostate cancer (mCRPC) patients treated with radium 223 (Ra-223) across the Yorkshire and Humber Cancer Network. MATERIALS AND METHODS: A regional, multicentre, retrospective cohort study of 189 men undergoing Ra-223 for mCRPC between March 2014 and April 2017 was undertaken. Factors predicting overall survival and completion of planned treatment were assessed. RESULTS: The median overall survival for the entire cohort was 10.5 months. Those completing five to six cycles of Ra-223 had a higher overall survival of 18.6 months. On multivariable analysis, four factors remained independent significant predictors of overall survival: age (P = 0.005, hazard ratio 1.07 [1.02-1.12]); number of cycles of Ra-223: 5-6 versus 1-4 (P ≤ 0.001, hazard ratio 0.10 [0.005-0.20]); baseline alkaline phosphatase (P = 0.044, hazard ratio 1.06 [1.002-1.12]); neutrophil-to-lymphocyte ratio (P = 0.033, hazard ratio 1.19 [1.01-1.40]). Baseline performance status 0 versus 2 (P = 0.026, odds ratio 0.080 [0.001-0.74]) and higher baseline haemoglobin (P = 0.028, odds ratio 1.04 [1.004-1.074]) were independent predictors of the completion of five to six cycles of Ra-223. CONCLUSIONS: Younger age, completion of five to six cycles of Ra-223, lower alkaline phosphatase and neutrophil-to-lymphocyte ratio are predictors of overall survival. This is the first study to report neutrophil-to-lymphocyte ratio as an independent predictor of overall survival in a Ra-223 cohort. Good performance status and higher baseline haemoglobin predict the completion of five to six cycles of Ra-223.


Subject(s)
Bone Neoplasms/drug therapy , Prostatic Neoplasms, Castration-Resistant/blood , Prostatic Neoplasms, Castration-Resistant/drug therapy , Radium/therapeutic use , Age Factors , Aged , Aged, 80 and over , Alkaline Phosphatase/blood , Bone Neoplasms/secondary , Health Status , Hemoglobins/metabolism , Humans , Lymphocyte Count , Male , Middle Aged , Neutrophils , Proportional Hazards Models , Prostatic Neoplasms, Castration-Resistant/pathology , Retrospective Studies , Survival Rate
3.
Clin Oncol (R Coll Radiol) ; 23(10): 674-80, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21788122

ABSTRACT

AIMS: Aromatase inhibitors are now a standard of care in the management of hormone-responsive early breast cancer in postmenopausal women. The troublesome side-effect of arthralgia remains a distinct clinical problem, with limited data on its aetiology and management. The aim of this questionnaire study was to evaluate the opinion of UK breast cancer clinicians on the importance of this treatment side effect. MATERIALS AND METHODS: In 2009, a questionnaire was sent to 772 breast surgeons and oncologists who manage breast cancer within the UK. The questionnaire evaluated the importance, investigation, management and the need for guidelines for aromatase inhibitor-induced arthralgia (AIA). RESULTS: Four hundred and sixteen (54%) returned questionnaires were suitable for analysis. By specialty, 234 (56%) were completed by breast surgeons, 134 (32%) by clinical oncologists, 45 (11%) by medical oncologists and one by a general surgeon. Three hundred and eighty-three (92%) specialists graded the importance of AIA as either very important or important; 211 (51%) did not know the aetiology of AIA; 280 (68%) did not perform bloods; 254 (61%) did not request radiology and 251 (60%) felt management was the responsibility of the oncologists. Three hundred and forty-nine (84%) considered that their practice would benefit from national guidelines. CONCLUSION: This questionnaire has highlighted that AIA is a major patient concern. Further research, educational initiatives and guidance are needed to improve the management of this treatment complication.


Subject(s)
Aromatase Inhibitors/adverse effects , Arthralgia/chemically induced , Breast Neoplasms/drug therapy , Aromatase Inhibitors/therapeutic use , Breast Neoplasms/surgery , Chemotherapy, Adjuvant , Female , Humans , Practice Guidelines as Topic , Randomized Controlled Trials as Topic , Surveys and Questionnaires , United Kingdom
4.
Clin Oncol (R Coll Radiol) ; 21(3): 161-7, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19111452

ABSTRACT

AIMS: A variety of radical radiotherapy regimens are in use for non-small cell lung cancer. Continuous hyperfractionated accelerated radiotherapy (CHART: 54 Gy in 36 fractions over 12 days) and accelerated hypofractionated radiotherapy using 55 Gy in 20 fractions over 4 weeks are standard fractionations in our centre. The primary aim of this retrospective study was to evaluate survival outcome seen in routine clinical practice. MATERIALS AND METHODS: All case notes and radiotherapy records of radically treated patients between 1999 and 2004 were retrospectively reviewed. Basic patient demographics, tumours, characteristics, radiotherapy and survival data were collected. RESULTS: In total, 277 patients received radical radiotherapy: 137 and 140 patients received CHART and hypofractionated radiotherapy, respectively. There were differences noted in the demographics between the two treatment schedules: median age 65 years (range 41-83) vs 73 years (range 33-87); histological confirmation rates 90% vs 76%; prior chemotherapy 34% vs 19% for CHART and hypofractionated treatment, respectively. For CHART patients, stages I, II, III and unclassified were 12, 8, 68 and 12% and the staging for the hypofractionated regimen was 54, 11, 34 and 2%, respectively. The median overall survival from the time of diagnosis was 20.4 months with a 40% 2-year survival rate. For the two fractionations the median survival was 16.6 months vs 21.4 months and 34% vs 45% of patients were alive at 2 years in the CHART and hypofractionated groups, respectively. On multivariate analysis, stage was the only factor affecting overall survival - no difference was seen according to radiotherapy regimen. CONCLUSION: This single-centre study reflects the outcome of unselected consecutively treated non-small cell lung cancer patients. Adjusting for stage, there was no significant difference in survival seen according to regimen. Encouragingly, CHART outcome shows reproducibility with the original CHART paper. Our hypofractionated outcome is similar to that previously reported, but despite this being the UK's most common regimen, 55 Gy in 20 daily fractions remains unvalidated by phase III trial data.


Subject(s)
Carcinoma, Non-Small-Cell Lung/radiotherapy , Lung Neoplasms/radiotherapy , Adult , Aged , Aged, 80 and over , Dose Fractionation, Radiation , Dose-Response Relationship, Radiation , Female , Humans , Male , Middle Aged , Neoplasm Recurrence, Local , Radiotherapy Planning, Computer-Assisted , Retrospective Studies , Survival Rate , Treatment Outcome
5.
J S Afr Vet Assoc ; 75(3): 147-9, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15628807

ABSTRACT

Fifteen of 100 mastitic milk samples from goats suffering from mastitis were tentatively identified as members of the genus Nocardia on the basis of selected phenotypic and chemotaxonomic characteristics. Six of the 155 strains were confirmed as Nocardia farcinica by 16S rDNA gene sequencing and subsequent aligning with relevant actinomycetes found in electronic databases and 2 by other identification criteria. N. farcinica is a serious cause of mastitis with a significant prevalence (15%) among the examined goats. Efforts are needed to optimise and simplify isolation and identification methods.


Subject(s)
Goat Diseases/microbiology , Mastitis/veterinary , Nocardia Infections/veterinary , Nocardia/isolation & purification , Animals , DNA, Ribosomal/analysis , DNA, Ribosomal/chemistry , Female , Goat Diseases/epidemiology , Goats , Mastitis/epidemiology , Mastitis/microbiology , Nocardia/classification , Nocardia/genetics , Nocardia Infections/epidemiology , Nocardia Infections/microbiology , Phenotype , Phylogeny , RNA, Ribosomal, 16S/genetics , Sudan/epidemiology
7.
Int Arch Allergy Immunol ; 119(2): 126-32, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10394104

ABSTRACT

Previous studies have suggested that intercellular adhesion molecule-1 (ICAM-1; CD54) may be involved in the pathogenesis of asthma. In addition, a soluble form of intercellular adhesion molecule-1 (sICAM-1) has been detected in increased concentrations in the sera from adult patients with certain inflammatory, immune, or malignant diseases. To determine whether bronchial asthma exacerbation in children is associated with increased levels of serum sICAM-1 and to investigate the effect of the severity of exacerbation on these levels, the concentrations of sICAM-1 were measured in sera of 20 healthy control children and 45 asthmatic children (15 with mild, 15 with moderate, and 15 with severe asthma exacerbation) using an immunoenzymatic assay. Assessment of the severity of asthma exacerbation was based on clinical and physiological parameters. The mean (+/- SD) level of serum sICAM-1 for asthmatic children (390.0+/-108.3 ng/ml) was significantly higher than that for healthy (193.2+/-33.95 ng/ml; p = 0.000). We have also found a differential rise of serum sICAM-1 level which correlates well with the severity of asthma exacerbation. The elevated concentrations of serum sICAM-1 in acute bronchial asthma may reflect the extensive inflammatory response occurring in the airways during acute exacerbation of the disease with airway obstruction. The results of this study suggest that serum sICAM-1 is a promising serological marker of the severity of inflammation in bronchial asthma in children and it would not only facilitate staging of inflammation but also allow the monitoring of therapy and intervention.


Subject(s)
Asthma/blood , Intercellular Adhesion Molecule-1/blood , Child , Female , Humans , Male , Respiratory Function Tests , Respiratory Mechanics , Severity of Illness Index , Solubility
8.
East Mediterr Health J ; 5(4): 664-75, 1999 Jul.
Article in English | MEDLINE | ID: mdl-11338688

ABSTRACT

To study the value of eosinophil cationic protein (ECP) as a serological marker of disease activity in childhood bronchial asthma, ECP levels were measured in 20 healthy control children and 25 asthmatic children, during and 2 weeks after acute exacerbation. The mean serum ECP level of all asthmatic patients, during and after exacerbation, was significantly higher than the control group and was significantly higher during attacks than 2 weeks after their termination. ECP levels were highest in severe attacks, but did not differ between mild and moderate attacks. ECP levels in asthmatic patients 2 weeks after mild and moderate attacks were comparable to normal; after severe attacks levels remained higher than normal. Measurement of serum ECP will be helpful in determining asthma activity and deciding the use of anti-asthma drugs.


Subject(s)
Asthma/blood , Blood Proteins/metabolism , Ribonucleases , Acute Disease , Adolescent , Asthma/classification , Asthma/diagnosis , Asthma/immunology , Biomarkers/blood , Blood Gas Analysis , Case-Control Studies , Child , Eosinophil Granule Proteins , Eosinophils , Female , Humans , Leukocyte Count , Male , Peak Expiratory Flow Rate , Radioimmunoassay , Severity of Illness Index , Time Factors
9.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-118752

ABSTRACT

To study the value of eosinophil cationic protein [ECP] as a serological marker of disease activity in childhood bronchial asthma, ECP levels were measured in 20 healthy control children and 25 asthmatic children, during and 2 weeks after acute exacerbation. The mean serum ECP level of all asthmatic patients, during and after exacerbation, was significantly higher than the control group and was significantly higher during attacks than 2 weeks after their termination. ECP levels were highest in severe attacks, but did not differ between mild and moderate attacks. ECP levels in asthmatic patients 2 weeks after mild and moderate attacks were comparable to normal; after severe attacks levels remained higher than normal. Measurement of serum ECP will be helpful in determining asthma activity and deciding the use of anti-asthma drugs


Subject(s)
Asthma , Eosinophils , Cations , Blood Proteins , Disease Progression
10.
Int J Oral Maxillofac Surg ; 25(1): 13-9, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8833294

ABSTRACT

This study assessed sensory nerve disturbance after Le Fort I osteotomy using the electric pulp test, pin-prick sensation, fine touch, and cold sensation. After 6 months, 78% of teeth positive preoperatively to an electric pulp tester regained sensitivity. Return of palatal sensation was affected by whether or not the greater palatine nerve (GPN) was divided during surgery. After 6 months, where the GPN was intact, all patients had fine touch sensation (88% at the preoperative level), and all had pin-prick sensation (97% at preoperative level). When the GPN was divided, all patients had fine touch sensation (13% at preoperative level), and all had pin-prick sensation (63% at preoperative level). The differences in the return to preoperative sensation were significant for fine touch (P=0.0001++) and for pin-prick (P-0.03) by chi-square analysis. Sensation returned more quickly and more completely in the two cases where the contralateral GPN was intact. In the buccal mucosa, 95% of patients regained some fine touch sensation after 6 months, but none returned to the preoperative level. Similarly, 85% regained some pin-prick sensation, but none achieved preoperative levels. Cold sensation, pin-prick sensation, and fine touch on the face returned to the preoperative level in all patients by 6 weeks postoperatively.


Subject(s)
Maxilla/surgery , Maxillary Nerve/physiopathology , Neurons, Afferent/physiology , Osteotomy, Le Fort/adverse effects , Sensation Disorders/etiology , Adolescent , Adult , Cold Temperature , Dental Pulp/innervation , Electric Stimulation , Face/innervation , Female , Follow-Up Studies , Gingiva/innervation , Humans , Male , Maxilla/innervation , Maxillary Nerve/surgery , Mouth Mucosa/innervation , Pain/physiopathology , Palate/innervation , Prospective Studies , Sensation , Skin/innervation , Touch
11.
J Pediatr ; 124(1): 131-8, 1994 Jan.
Article in English | MEDLINE | ID: mdl-8283363

ABSTRACT

The efficacy of albuterol in the management of infants with first-time wheezing is controversial. This double-blind, placebo-controlled trial involved 128 Egyptian infants with first-time wheezing (mean age 5.9 months) who were randomly separated into four equivalent therapy groups: nebulized albuterol, nebulized saline solution, orally administered albuterol, and orally administered placebo. The nebulized therapy groups received two treatments 30 minutes apart; the oral therapy groups received one treatment. In addition, 41 infants with recurrent wheezing comprised an open-label control group who received two albuterol nebulizations. Chest radiographs, leukocyte counts, blood culture specimens, and nasal aspirate for viral antigen detection were obtained to confirm the clinical diagnosis of viral bronchiolitis. Respiratory and heart rates, clinical score, and oxygen saturation were recorded at baseline and 30 and 60 minutes after treatment. There was no difference among the four randomized groups in any of the outcomes except for an increase in heart rate of 10 beats/min in the nebulized albuterol group compared with a decrease in heart rate of 8 beats/min in the oral placebo group. No differences in the need for additional treatment were observed. Nebulized albuterol significantly improved the clinical score and reduced the respiratory rate of those with recurrent wheezing relative to those in the randomized groups. We conclude that nebulized albuterol is effective in the treatment of infants with recurrent wheezing, but there was no demonstrable efficacy of orally administered or nebulized albuterol in relieving the respiratory distress of infants with bronchiolitis in Egypt.


Subject(s)
Albuterol/therapeutic use , Bronchiolitis/drug therapy , Administration, Oral , Albuterol/administration & dosage , Analysis of Variance , Double-Blind Method , Egypt , Female , Humans , Infant , Male , Nebulizers and Vaporizers , Prospective Studies , Treatment Outcome
13.
Ukr Biokhim Zh ; 48(1): 122-7, 1976.
Article in Ukrainian | MEDLINE | ID: mdl-130703

ABSTRACT

Statistical methods are considered for eliminating the errors caused by the individual fluctuations of the animals organs weight, different ratio of organs weight to the weight statistical processing the data on the dynamics of labelled nicotinic acid evacuation and determination of the acid half-life in the rat liver. The mean liver weight was estimated by means of Huxley's allometry formula. Dynamics of NA was approximated by using the formula kappa=ate-betat in the computer "MHP-2" and the least squares method.


Subject(s)
Liver/metabolism , Niacinamide/deficiency , Nicotinic Acids/metabolism , Analysis of Variance , Animals , Mathematics , Organ Size , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...